Emergent BioSolutions Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Emergent BioSolutions Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2014 to Q2 2024.
  • Emergent BioSolutions Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $16.3M, a 1.24% increase year-over-year.
  • Emergent BioSolutions Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $65M, unchanged year-over-year.
  • Emergent BioSolutions Inc. annual Amortization of Intangible Assets for 2023 was $65.6M, a 9.52% increase from 2022.
  • Emergent BioSolutions Inc. annual Amortization of Intangible Assets for 2022 was $59.9M, a 2.39% increase from 2021.
  • Emergent BioSolutions Inc. annual Amortization of Intangible Assets for 2021 was $58.5M, a 2.17% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $65M $16.3M +$200K +1.24% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $64.8M $16.2M -$800K -4.71% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $65.6M $16.2M -$1.7M -9.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $67.3M $16.3M +$2.3M +16.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-12-11
Q2 2023 $65M $16.1M +$2.1M +15% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $62.9M $17M +$3M +21.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $59.9M $17.9M +$3.9M +27.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $56M $14M -$500K -3.45% Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-11
Q2 2022 $56.5M $14M -$1.1M -7.29% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $57.6M $14M -$900K -6.04% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $58.5M $14M -$1M -6.67% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-08
Q3 2021 $59.5M $14.5M -$500K -3.33% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $60M $15.1M +$100K +0.67% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $59.9M $14.9M +$100K +0.68% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $59.8M $15M +$200K +1.35% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-12-11
Q3 2020 $59.6M $15M +$300K +2.04% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $59.3M $15M +$300K +2.04% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $59M $14.8M +$300K +2.07% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $58.7M $14.8M +$1.5M +11.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $57.2M $14.7M +$10.8M +277% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $46.4M $14.7M +$10.8M +277% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $35.6M $14.5M +$10.6M +272% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $25M $13.3M +$9.45M +246% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $15.5M $3.9M +$2.3M +144% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $13.2M $3.9M +$2.3M +144% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $10.9M $3.9M +$2.35M +151% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $8.6M $3.85M +$2.18M +131% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $6.42M $1.6M -$51K -3.09% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $6.47M $1.6M -$243K -13.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $6.71M $1.55M -$289K -15.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $7M $1.66M +$665K +66.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 $6.34M $1.65M -$193K -10.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $6.53M $1.84M -$549K -23% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $7.08M $1.84M -$299K -14% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $7.38M $998K -$3.17M -76% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-23
Q3 2015 $10.5M $1.84M -$371K -16.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $10.9M $2.39M +$143K +6.36% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $10.8M $2.14M +$3.78M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $6.99M $4.16M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $2.22M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $2.25M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$1.64M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.